ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.15860C>T (p.Thr5287Met)

gnomAD frequency: 0.00076  dbSNP: rs148551876
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000222088 SCV000270975 likely benign not specified 2015-06-04 criteria provided, single submitter clinical testing p.Thr4043Met in exon 51 of TTN: This variant is not expected to have clinical si gnificance because it has been identified in 0.3% (33/9780) of African chromosom es by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; db SNP rs148551876).
Invitae RCV000560779 SCV000642714 likely benign Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2024-01-25 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000222088 SCV000701150 likely benign not specified 2016-11-09 criteria provided, single submitter clinical testing
GeneDx RCV000222088 SCV000730337 likely benign not specified 2017-12-05 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000222088 SCV001426793 benign not specified 2020-07-13 criteria provided, single submitter clinical testing Variant summary: TTN c.12128C>T (p.Thr4043Met) results in a non-conservative amino acid change located in the I-band region of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00028 in 248540 control chromosomes, predominantly at a frequency of 0.0036 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 6-fold of the estimated maximal expected allele frequency for a pathogenic variant in TTN causing Cardiomyopathy phenotype (0.00063), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.12128C>T has been reported in the literature in a pediatric patient affected with Dilated Cardiomyopathy who also carried a PKP2 pathogenic variant (c.663C>A, p.Y221X; Headrick_2019). This report does not provide unequivocal conclusions about association of the variant with Cardiomyopathy. An additional co-occurrence with a pathogenic variant has been reported via internal testing (TTR c.424G>A, p.Val142Ile). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four ClinVar submitters (evaluation after 2014) cite the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign.
Genome-Nilou Lab RCV001840333 SCV002100055 benign Autosomal recessive limb-girdle muscular dystrophy type 2J 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001840334 SCV002100057 benign Myopathy, myofibrillar, 9, with early respiratory failure 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001840335 SCV002100058 benign Early-onset myopathy with fatal cardiomyopathy 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001840332 SCV002100059 benign Tibial muscular dystrophy 2021-09-10 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003937844 SCV004755379 likely benign TTN-related condition 2020-03-09 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.